Sponsor

Sparrow Pharmaceuticals Inc.

United States 920 Southwest 6th Avenue, 97204-1239, United States

About the sponsor

Sparrow Pharmaceuticals Inc. focuses on clinical research in Cushing's syndrome, including ACTH-dependent forms such as Cushing's disease, ectopic ACTH secretion, and ectopic corticotrophin-releasing hormone–driven disease. The sponsor's work in this area centers on disorders of excess cortisol production and related endocrine dysregulation.

Endocrinology
Hypercortisolism
Adrenal and pituitary disorders

Its trial portfolio also includes patients with hypercortisolism linked to benign adrenal tumours and autonomous cortisol secretion.

About Specializations

Sparrow Pharmaceuticals Inc. runs clinical trials in conditions such as Pituitary-dependent Cushing's syndrome, Hyperadrenocorticism, Polymyalgia rheumatica, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

3 clinical trials

Pituitary-dependent Cushing's syndrome

Not recruiting

Study of SPI-62 for Treating ACTH-Dependent Cushing's Syndrome in Patients with Cushing's Disease or Ectopic ACTH/CRH Secretion

InvestigationalNo placebo

Study of SPI-62 for Treating ACTH-Dependent Cushing's Syndrome in Patients with Cushing's Disease or Ectopic ACTH/CRH Secretion

InvestigationalNo placebo

Bulgaria

Participants:18–64 years
Substances:Clofutriben
Sponsor:Sparrow Pharmaceuticals Inc.

Contact Research Centre

Hyperadrenocorticism

Not recruiting

Study of SPI-62 for Treating Cushing's Syndrome in Patients with Benign Adrenal Tumors

InvestigationalNo placebo

Study of SPI-62 for Treating Cushing's Syndrome in Patients with Benign Adrenal Tumors

InvestigationalNo placebo

Romania

Participants:18–64 years · 65+ years
Substances:4-{5-[2-(4-Chloro-2,6-Difluorophenoxy)Propan-2-Yl]-4-Methyl-4H-1,2,4-Triazol-3-Yl}-3-Fluorobenzamide
Sponsor:Sparrow Pharmaceuticals Inc.